Algernon Pharmaceuticals Inc (AGNPF)
0.082
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Algernon Pharmaceuticals Total Liabilities (Quarterly): 1.647M for Nov. 30, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| November 30, 2022 | 1.647M |
| August 31, 2022 | 1.922M |
| May 31, 2022 | 1.065M |
| February 28, 2022 | 1.130M |
| November 30, 2021 | 0.4905M |
| August 31, 2021 | 0.8106M |
| May 31, 2021 | 1.573M |
| February 28, 2021 | 1.237M |
| November 30, 2020 | 0.8693M |
| August 31, 2020 | 0.464M |
| May 31, 2020 | 0.8002M |
| February 29, 2020 | 0.1769M |
| November 30, 2019 | 0.2499M |
| August 31, 2019 | 0.2734M |
| May 31, 2019 | 0.1724M |
| Date | Value |
|---|---|
| February 28, 2019 | 0.1081M |
| November 30, 2018 | 0.1832M |
| August 31, 2018 | 0.0439M |
| May 31, 2018 | 0.0077M |
| February 28, 2018 | 0.0269M |
| November 30, 2017 | 0.0323M |
| August 31, 2017 | 0.0378M |
| May 31, 2017 | 0.0225M |
| February 28, 2017 | 0.0721M |
| November 30, 2016 | 0.1224M |
| August 31, 2016 | 0.1149M |
| May 31, 2016 | 0.0488M |
| February 29, 2016 | 0.0469M |
| November 30, 2015 | 0.0949M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.1769M
Minimum
Feb 2020
1.922M
Maximum
Aug 2022
0.9077M
Average
0.8399M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.56M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.912M |
| Shareholders Equity (Quarterly) | 3.265M |